Improvements in Albuminuria Screening Among Individuals with Hypertension Associated with Electronic Health Record Clinical Decision Support Design Changes
Preprint
Abstract
Background: Albuminuria is associated with increased risk of cardiovascular disease (CVD), heart failure, and progression of chronic kidney disease (CKD). Early detection of albuminuria, done through spot urine albumin creatinine ratio (UACR) testing, enables more accurate risk stratification and timely use of preventative therapies. It remains unacceptably low in the hypertension population. Methods: We evaluated two EHR-embedded clinical decision support (CDS) strategies at Geisinger Health System in order to increase UACR testing in individuals with hypertension: an OurPractice Advisory (OPA) from Jan 2022 to Aug 2022; and a Health Maintenance Topic (HMT) in the Care Gaps section of Storyboard from Aug 2022 that continues to date. We evaluated UACR rates from 2020 to 2023 in Geisinger primary care and compared to a control group of healthcare systems in the Optum Labs Data Warehouse [OLDW]. Patients were excluded if they had UACR testing in the preceding 3 years, had diabetes or CKD, or were receiving palliative/hospice care. Results: We included 58,876 individuals in Geisinger (mean age 59.4 years, 49.6% female) and 1,427,754 in OLDW (61.0 years, 49% female). UACR testing in Geisinger (2.97% in 2020; 2.8% in 2021; 9.7% in 2022; 17.5% in 2023) showed significant increase compared to the control health systems (2.08%, 2.26%, 3.35% and 3.40% respectively). Results were consistent after adjusting for age, sex and race. Conclusion: OPA increased UACR testing ∼3-fold whereas the HMT was associated with further improvements (∼6-fold vs. baseline) among those with hypertension, suggesting an important role for CDS design in closing care gaps.Keywords
This publication has 34 references indexed in Scilit:
- Electronic Health Record Population Health Management for Chronic Kidney Disease CareJAMA Internal Medicine, 2024
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney DiseaseKidney International, 2024
- Evaluation of a Best-Practice Advisory for Primary Aldosteronism ScreeningJAMA Internal Medicine, 2024
- A CKD Clinical Decision Support System: A Cluster Randomized Clinical Trial in Primary Care ClinicsKidney Medicine, 2023
- Estimated Prevalence and Testing for Albuminuria in US Adults at Risk for Chronic Kidney DiseaseJAMA Network Open, 2023
- KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney DiseaseKidney International, 2022
- Geisinger's effort to realize its potential as a learning health system: A progress reportLearning Health Systems, 2020
- User Requirements for a Chronic Kidney Disease Clinical Decision Support Tool to Promote Timely ReferralInternational Journal of Medical Informatics, 2017
- Interdisciplinary training to build an informatics workforce for precision medicineApplied & Translational Genomics, 2015
- Albuminuria and Risk of Cardiovascular Events, Death, and Heart Failure in Diabetic and Nondiabetic IndividualsJAMA, 2001